The global gastrointestinal stent market holds a valuation of US$ 455.44 Million by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 5.5%, and is expected to hold a market value of around US$ 815.34 Million in 2033.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 455.44 Million |
| Market Value 2023 | US$ 476.72 Million |
| Market Value 2033 | US$ 815.34 Million |
| CAGR 2023 to 2033 | 5.51% |
| Market Share of Top 5 Countries | 65.3% |
| Key Market Players | Boston Scientific Corporation, Hobbs Medical Inc., Taewoong Medical, Micro–Tech (Nanjing) Co., Ltd., Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson Services, Inc., 3M, Smith & Nephew, Diagmed Healthcare, Medline Industries, Inc., Baxter, B. Braun Melsungen AG, Danaher Corporation, General Electric Company, Cantel Medical Corporation, ConvaTec Inc., and M.C. Johnson Company, Inc. |
An artificial tube graft called gastrointestinal (GI) stent is put into the body to prevent obstructions in the stomach, oesophagus, and small intestine. It is an expandable metal or plastic mesh tube that is inserted into an anatomical duct to treat blockages brought on by malignant tissues in the bile ducts, oesophagus, intestine, or colon. It helps to eliminate the blockage and reduce the pressure caused by inflammation. A few of the most prevalent types of gastrointestinal stents are biliary, colonic, duodenal, esophageal, and pancreatic stents.
One of the main factors fuelling the market's expansion is the increased incidence of colorectal cancer in the world and rising geriatric population with gastrointestinal conditions such as diverticulosis, bowel disorders, and gastrointestinal cancers.
As per the World Health Organization (WHO), in 2020, colorectal cancer caused more than 1.9 million new cases and more than 930,000 deaths worldwide. By 2040, there will be 3.2 million new occurrences of colorectal cancer annually (an increase of 63%) and 1.6 million annual fatalities (an increase of 73%).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The gastrointestinal stent market expanded at a CAGR of 3.8% between 2017 and 2022 period due to numerous medical advancements and studies to upgrade diagnostic technologies, as well as the rise in demand for less invasive surgical treatments.
The global gastrointestinal stent contributed around 4.3% revenue share to the US$ 10.5 Billion gastrointestinal devices market in 2022.
Gastrointestinal stents are made to provide palliative care for a variety of illnesses that obstruct the GI tract. In the recanalization of gastrointestinal tumors and postoperative leak sealing, GI stents play a significant role. Drug–eluting devices, tissue modelling for benign conditions, and GI tract drainage/anastomosis are some additional potential uses for GI stents. The market for gastrointestinal stents is attributed to changing lifestyles and the rising incidence of GI cancers and other digestive diseases.
The stent manufacturers are also focusing on product development with the use of smart phone application and more market penetration for the product. Other factors expected to drive market growth include the implementation of advantageous government policies, significant expansion of healthcare infrastructure, and extensive research and development efforts, and increased focus by diagnostic laboratories on adoption of advanced technologies.
The increasing prevalence of cancer, growing demand for minimally invasive surgical procedures, development of advanced diagnostic technologies and rising disposable income, all these factors promotes the growth of global market over the forecast period.
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 3.29% |
| Jul to Dec (H2), 2021 (A) | 4.71% |
| Jan to Jun (H1),2022 Projected (P) | 3.47% |
| Jan to Jun (H1),2022 Outlook (O) | 3.73% |
| Jul to Dec (H2), 2022 Outlook (O) | 4.81% |
| Jul to Dec (H2), 2022 Projected (P) | 4.46% |
| Jan to Jun (H1), 2023 Projected (P) | 4.25% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 25 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 44 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 35 ↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (A) | 10 ↑ |
Principal Consultant
One of the biggest causes of death around the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, gastrointestinal digestive disorders, etc., have sharply increased in recent years.
According to statistics on cancer published in the International Journal of Cancer 2020, stomach cancer accounted for about 1.1 million new cases worldwide in 2020 and was the fourth leading cause of cancer death, accounting for about 800,000 deaths. It was also the fifth most common malignant tumor worldwide.
Companies have been manufacturing products like biodegradable stents made of biodegradable materials like polyester, polycarbonate, bacterially produced polymers etc. with the potential to elute drugs. Drug–stents can reduce lumen occlusion rates by delivering targeted drugs directly to tissue in addition to radial expansion to maintain luminal potency. As they progressively break down and are finally absorbed from the GI, biodegradable stents also aid in preserving the digestive tract's functionality for a certain period. Above factors are expected to boost market growth and provide lucrative opportunities to the players globally.
Medical device approval regulations that are too strict will impede the market's expansion. The market growth rate will be further slowed down by unfavourable reimbursement circumstances in developing and underdeveloped economies along with stent–related complications. Biliary stents, as an example, exhibit early problems such as bleeding, infection, and pancreatitis. Esophageal stent therapy can cause painful foreign body symptoms and pulmonary aspiration as side effects.
The cost of healthcare has risen dramatically over the world in recent years, as have the prices of medical equipment. Healthcare providers and payers have limited financial means to spend on such a pricey surgery in developing nations like India and Brazil. In addition, Government in many Asian nations does not provide the healthcare coverage for endoscopic stenting treatments, which is one of the key reasons for patient and physician resistance to gastrointestinal stents. The absence of reimbursement in developing countries like India together with high product cost are expected to hinder the market growth in future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The USA |
|---|---|
| Market Share (2023) | 41.9% |
| Market Share (2033) | 43.7% |
| BPS Analysis | 180 |
| Country | Germany |
|---|---|
| Market Share (2023) | 7.5% |
| Market Share (2033) | 8.2% |
| BPS Analysis | 66 |
| Country | The United Kingdom |
|---|---|
| Market Share (2023) | 6.2% |
| Market Share (2033) | 5.8% |
| BPS Analysis | –42 |
| Country | China |
|---|---|
| Market Share (2023) | 4.7% |
| Market Share (2033) | 4.5% |
| BPS Analysis | –26 |
| Country | France |
|---|---|
| Market Share (2023) | 4.7% |
| Market Share (2033) | 4.4% |
| BPS Analysis | –25 |
The USA will dominate the global market in 2023 with a market share of 41.9%.
Presence of large number of players, increasing cases of cancer, advantageous medical reimbursement policies, advanced levels of healthcare technologies, greater adoption of minimally invasive surgeries have made the U.S. market to dominate globally.
According to data from the American Cancer Society, nearly 43,030 new cases of rectal cancer and around 97,220 new cases of colon cancer were reported in 2018, and the number of cases have been increasing.
Germany is set to hold a market share of 7.5% in 2023 within the global market.
In recent years, the role of stenting in the management of patients with digestive tract obstruction in Germany has expanded to include the oesophagus, stomach, small bowel, and colon. Recent technological advancements have improved stent patency and reduced stent–induced complications, resulting in a higher quality of life.
To avoid migration, a new device called Stentfix OTSC System has been developed in 2020. It is made up of a Nitinol clip that is preloaded on the applicator cap and is used to clip the flared end of FCSEMS (Fully Covered Self Expanding Metal Stent) to the gastrointestinal mucosal layer. Germany also has a large accessible medical facility, both of which are expected to increase demand for stents in the market.
The China market is set to hold around 4.7% revenue share in 2023 within the global market.
China market is increasing due to rising prevalence of gastrointestinal cancer and diseases. According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.
Another factor is the ongoing development of GI stents for various applications in order to expand treatment options and reduce complications.
Biliary stent product sale will exhibit 43.5% of the global market share in 2023.
One of the main factors driving the growth of the biliary stents market is the rising prevalence of bile duct cancer, chronic liver disease, rising gallstones patients, technological advancement for devices, increasing geriatric population, and various surgical procedure to cure biliary diseases.
Within the material category, self–expanding metal stent are expected to lead the global market with the market share of around 65.7% in 2023.
Factors responsible for the growth of this segment include an increase in demand for self–expanding metal stents due to benefits such as ease of insertion, reduced risk of dislodgment or migration, and extended patience
The growing prevalence and occurrences of pancreatic cancers are responsible for the segment's growth with an expected market share of 27.6% in 2023 globally.
According to published report of the American Cancer Society's on pancreatic cancer statistics in 2023, 33,130 males and 30,920 females will be diagnosed with the disease in the USA Furthermore, pancreatic cancer accounts for about 3% of cancer cases and 7% of cancer–related deaths in the USA
Increasing the use of biodegradable stents for the treatment of pancreatic cancer, which results in good palliation for patients during their remaining life span with no serious risks or complications would drive market growth.
In 2023, hospitals and clinics will dominate the global market with 63.5%.
The large share of this segment can be attributed to a large number of percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in hospital settings for various disease symptoms, increased government initiatives to provide standard gastrointestinal disease treatment and durable reimbursement scenarios.
The gastrointestinal stent industry is moderately competitive, with several global and regional companies. The need for stents in gastrointestinal endoscopy increases as the prevalence of diseases connected with the gastrointestinal tract rises. As a result, most big corporations are adopting growth plans to reach out to emerging markets by new product launch.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the gastrointestinal stent market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa. |
| Key Market Segments Covered | Product, Material, Application, End User, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The growth potential of the gastrointestinal stent market is 5.5% through 2033.
The high cost of adoption is likely to limit market growth.
The United States is likely to capture a share of 43.7% by 2033.
The market in China will capture a share of 4.7% by 2033.
The United States, China, and the United Kingdom may witness significant growth in the market.
1. Executive Summary | Gastrointestinal Stent Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption/Usage Analysis
4.2. Key Promotional Strategies, by Manufacturers
4.3. Key Regulations
4.4. PESTEL Analysis
4.5. Porter’s Analysis
4.6. Disease Epidemiology
4.7. Product Launch Activities
4.8. Reimbursement Scenario
4.9. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Gastrointestinal Devices Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. New Product Launches and Approvals
5.2.3. Growing incidence of Gastrointestinal Epidemiology
5.2.4. R&D Expenditure by Key Players
5.2.5. Historic and Current Revenue of key players
5.2.6. Rising Consumer Awareness of the Product
5.2.7. Rising Adoption of Device Technological development
5.2.8. Strategic Developments by Key Players
5.2.9. Increase Adoption of Gastrointestinal Care & Cancer Care for Various Materials
5.2.10. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Material
6.1.3. By Application
6.1.4. By End User
6.1.5. By Country
6.2. 2022 Market Scenario
7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2017 to 2022
7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2017 to 2022
9.2. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Product, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033
10.3.1. Biliary Stents
10.3.2. Duodenal Stents
10.3.3. Colonic Stents
10.3.4. Pancreatic Stents
10.3.5. Esophageal Stents
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Material
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis by Material, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Material, 2023 to 2033
11.3.1. Self – Expanding Metal Stents
11.3.2. Plastic Stents
11.4. Market Attractiveness Analysis by Material
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
12.3.1. Biliary Diseases
12.3.2. Irritable Bowel Syndrome
12.3.3. Gastrointestinal Cancers
12.3.4. Colorectal Cancer
12.3.5. Stomach Cancer
12.3.6. Esophageal Cancer
12.3.7. Pancreatic Cancer
12.4. Market Attractiveness Analysis by Application
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
13.3.1. Hospitals and Clinics
13.3.2. Ambulatory Surgical Centers
13.4. Market Attractiveness Analysis by End User
14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) and Volume Analysis, by Region, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis Forecast by Region, 2023 to 2033
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. The Middle East & Africa
14.4. Market Attractiveness Analysis by Region
15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. USA
15.3.1.2. Canada
15.3.2. By Product
15.3.3. BY Application
15.3.4. By Material
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Material
15.4.4. By Application
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. USA Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Material
15.8.1.2.3. By Application
15.8.1.2.4. By End User
15.8.2. Canada Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Material
15.8.2.2.3. By Application
15.8.2.2.4. By End User
16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Mexico
16.3.1.2. Brazil
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Material
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Material
16.4.4. By Application
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Mexico Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Material
16.8.1.2.3. By Application
16.8.1.2.4. By End User
16.8.2. Brazil Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Material
16.8.2.2.3. By Application
16.8.2.2.4. By End User
16.8.3. Argentina Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Material
16.8.3.2.3. By Application
16.8.3.2.4. By End User
17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. United Kingdom
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Product
17.3.3. By Material
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Material
17.4.4. By Application
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Germany Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Material
17.8.1.2.3. By Application
17.8.1.2.4. By End User
17.8.2. Italy Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Material
17.8.2.2.3. By Application
17.8.2.2.4. By End User
17.8.3. France Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Material
17.8.3.2.3. By Application
17.8.3.2.4. By End User
17.8.4. United Kingdom Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Material
17.8.4.2.3. By Application
17.8.4.2.4. By End User
17.8.5. Spain Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Material
17.8.5.2.3. By Application
17.8.5.2.4. By End User
17.8.6. BENELUX Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Material
17.8.6.2.3. By Application
17.8.6.2.4. By End User
17.8.7. Russia Market Analysis
17.8.7.1. Introduction
17.8.7.2. Market Analysis and Forecast by Market Taxonomy
17.8.7.2.1. By Product
17.8.7.2.2. By Material
17.8.7.2.3. By Application
17.8.7.2.4. By End User
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Material
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Material
18.4.4. By Application
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. China Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Material
18.8.1.2.3. By Application
18.8.1.2.4. By End User
18.8.2. Japan Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Material
18.8.2.2.3. By Application
18.8.2.2.4. By End User
18.8.3. South Korea Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Material
18.8.3.2.3. By Application
18.8.3.2.4. By End User
19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Malaysia
19.3.1.4. Thailand
19.3.1.5. Rest of South Asia
19.3.2. By Product
19.3.3. By Material
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Material
19.4.4. By Application
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. India Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Material
19.8.1.2.3. By Application
19.8.1.2.4. By End User
19.8.2. Indonesia Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Material
19.8.2.2.3. By Application
19.8.2.2.4. By End User
19.8.3. Malaysia Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Material
19.8.3.2.3. By Application
19.8.3.2.4. By End User
19.8.4. Thailand Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Material
19.8.4.2.3. By Application
19.8.4.2.4. By End User
20. Oceania Market 2017 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Material
20.3.4. By Application
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Material
20.4.3. By Application
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. Australia Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Material
20.8.1.2.3. By Application
20.8.1.2.4. By End User
20.8.2. New Zealand Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Material
20.8.2.2.3. By Application
20.8.2.2.4. By End User
21. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2017 to 2022
21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Türkiye
21.3.1.3. North Africa
21.3.1.4. South Africa
21.3.1.5. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Material
21.3.4. By Application
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Material
21.4.4. By Application
21.4.5. By End User
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
21.8. Country Level Analysis & Forecast
21.8.1. GCC Countries Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By Material
21.8.1.2.3. By Application
21.8.1.2.4. By End User
21.8.2. Türkiye Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By Material
21.8.2.2.3. By Application
21.8.2.2.4. By End User
21.8.3. South Africa Market Analysis
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast by Market Taxonomy
21.8.3.2.1. By Product
21.8.3.2.2. By Material
21.8.3.2.3. By Application
21.8.3.2.4. By End User
21.8.4. North Africa Market Analysis
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast by Market Taxonomy
21.8.4.2.1. By Product
21.8.4.2.2. By Material
21.8.4.2.3. By Application
21.8.4.2.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Boston Scientific Corporation
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Sales Footprint
23.3.1.4. Key Financials
23.3.1.5. SWOT Analysis
23.3.1.6. Key Developments
23.3.1.7. Strategy Overview
23.3.1.7.1. Marketing Strategy
23.3.1.7.2. Product Strategy
23.3.1.7.3. Channel Strategy
23.3.2. Hobbs Medical Inc.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Sales Footprint
23.3.2.4. Key Financials
23.3.2.5. SWOT Analysis
23.3.2.6. Key Developments
23.3.2.7. Strategy Overview
23.3.2.7.1. Marketing Strategy
23.3.2.7.2. Product Strategy
23.3.2.7.3. Channel Strategy
23.3.3. Taewoong Medical
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Sales Footprint
23.3.3.4. Key Financials
23.3.3.5. SWOT Analysis
23.3.3.6. Key Developments
23.3.3.7. Strategy Overview
23.3.3.7.1. Marketing Strategy
23.3.3.7.2. Product Strategy
23.3.3.7.3. Channel Strategy
23.3.4. Micro-Tech (Nanjing) Co., Ltd.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Sales Footprint
23.3.4.4. Key Financials
23.3.4.5. SWOT Analysis
23.3.4.6. Key Developments
23.3.4.7. Strategy Overview
23.3.4.7.1. Marketing Strategy
23.3.4.7.2. Product Strategy
23.3.4.7.3. Channel Strategy
23.3.5. Olympus Corporation
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Sales Footprint
23.3.5.4. Key Financials
23.3.5.5. SWOT Analysis
23.3.5.6. Key Developments
23.3.5.7. Strategy Overview
23.3.5.7.1. Marketing Strategy
23.3.5.7.2. Product Strategy
23.3.5.7.3. Channel Strategy
23.3.6. Merit Medical Systems
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Sales Footprint
23.3.6.4. Key Financials
23.3.6.5. SWOT Analysis
23.3.6.6. Key Developments
23.3.6.7. Strategy Overview
23.3.6.7.1. Marketing Strategy
23.3.6.7.2. Product Strategy
23.3.6.7.3. Channel Strategy
23.3.7. Qualimed
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Sales Footprint
23.3.7.4. Key Financials
23.3.7.5. SWOT Analysis
23.3.7.6. Key Developments
23.3.7.7. Strategy Overview
23.3.7.7.1. Marketing Strategy
23.3.7.7.2. Product Strategy
23.3.7.7.3. Channel Strategy
23.3.8. Medtronic
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Sales Footprint
23.3.8.4. Key Financials
23.3.8.5. SWOT Analysis
23.3.8.6. Key Developments
23.3.8.7. Strategy Overview
23.3.8.7.1. Marketing Strategy
23.3.8.7.2. Product Strategy
23.3.8.7.3. Channel Strategy
23.3.9. Conmed Corporation
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Sales Footprint
23.3.9.4. Key Financials
23.3.9.5. SWOT Analysis
23.3.9.6. Key Developments
23.3.9.7. Strategy Overview
23.3.9.7.1. Marketing Strategy
23.3.9.7.2. Product Strategy
23.3.9.7.3. Channel Strategy
23.3.10. Terumo Corporation
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Sales Footprint
23.3.10.4. Key Financials
23.3.10.5. SWOT Analysis
23.3.10.6. Key Developments
23.3.10.7. Strategy Overview
23.3.10.7.1. Marketing Strategy
23.3.10.7.2. Product Strategy
23.3.10.7.3. Channel Strategy
23.3.11. Johnson & Johnson Services, Inc.
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Sales Footprint
23.3.11.4. Key Financials
23.3.11.5. SWOT Analysis
23.3.11.6. Key Developments
23.3.11.7. Strategy Overview
23.3.11.7.1. Marketing Strategy
23.3.11.7.2. Product Strategy
23.3.11.7.3. Channel Strategy
23.3.12. 3M
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Sales Footprint
23.3.12.4. Key Financials
23.3.12.5. SWOT Analysis
23.3.12.6. Key Developments
23.3.12.7. Strategy Overview
23.3.12.7.1. Marketing Strategy
23.3.12.7.2. Product Strategy
23.3.12.7.3. Channel Strategy
23.3.13. Smith & Nephew
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Sales Footprint
23.3.13.4. Key Financials
23.3.13.5. SWOT Analysis
23.3.13.6. Key Developments
23.3.13.7. Strategy Overview
23.3.13.7.1. Marketing Strategy
23.3.13.7.2. Product Strategy
23.3.13.7.3. Channel Strategy
23.3.14. Diagmed Healthcare
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Sales Footprint
23.3.14.4. Key Financials
23.3.14.5. SWOT Analysis
23.3.14.6. Key Developments
23.3.14.7. Strategy Overview
23.3.14.7.1. Marketing Strategy
23.3.14.7.2. Product Strategy
23.3.14.7.3. Channel Strategy
23.3.15. Medline Industries, Inc.
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Sales Footprint
23.3.15.4. Key Financials
23.3.15.5. SWOT Analysis
23.3.15.6. Key Developments
23.3.15.7. Strategy Overview
23.3.15.7.1. Marketing Strategy
23.3.15.7.2. Product Strategy
23.3.15.7.3. Channel Strategy
23.3.16. Baxter
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Sales Footprint
23.3.16.4. Key Financials
23.3.16.5. SWOT Analysis
23.3.16.6. Key Developments
23.3.16.7. Strategy Overview
23.3.16.7.1. Marketing Strategy
23.3.16.7.2. Product Strategy
23.3.16.7.3. Channel Strategy
23.3.17. B. Braun Melsungen AG
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Sales Footprint
23.3.17.4. Key Financials
23.3.17.5. SWOT Analysis
23.3.17.6. Key Developments
23.3.17.7. Strategy Overview
23.3.17.7.1. Marketing Strategy
23.3.17.7.2. Product Strategy
23.3.17.7.3. Channel Strategy
23.3.18. Danaher Corporation
23.3.18.1. Overview
23.3.18.2. Product Portfolio
23.3.18.3. Sales Footprint
23.3.18.4. Key Financials
23.3.18.5. SWOT Analysis
23.3.18.6. Key Developments
23.3.18.7. Strategy Overview
23.3.18.7.1. Marketing Strategy
23.3.18.7.2. Product Strategy
23.3.18.7.3. Channel Strategy
23.3.19. Cantel Medical Corporation
23.3.19.1. Overview
23.3.19.2. Product Portfolio
23.3.19.3. Sales Footprint
23.3.19.4. Key Financials
23.3.19.5. SWOT Analysis
23.3.19.6. Key Developments
23.3.19.7. Strategy Overview
23.3.19.7.1. Marketing Strategy
23.3.19.7.2. Product Strategy
23.3.19.7.3. Channel Strategy
23.3.20. ConvaTec Inc.
23.3.20.1. Overview
23.3.20.2. Product Portfolio
23.3.20.3. Sales Footprint
23.3.20.4. Key Financials
23.3.20.5. SWOT Analysis
23.3.20.6. Key Developments
23.3.20.7. Strategy Overview
23.3.20.7.1. Marketing Strategy
23.3.20.7.2. Product Strategy
23.3.20.7.3. Channel Strategy
23.3.21. M.C. Johnson Company, Inc.
23.3.21.1. Overview
23.3.21.2. Product Portfolio
23.3.21.3. Sales Footprint
23.3.21.4. Key Financials
23.3.21.5. SWOT Analysis
23.3.21.6. Key Developments
23.3.21.7. Strategy Overview
23.3.21.7.1. Marketing Strategy
23.3.21.7.2. Product Strategy
23.3.21.7.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Explore Healthcare Insights
View Reports
Gastrointestinal Stent Market
